AstraZeneca Group plc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (68)

Latest Posts

About This Stock More About This Stock
AstraZeneca Says Its COVID-19 Vaccine Produces Robust Immune Response In Elderly Patients
Article By: Tyler Durden
Monday, October 26, 2020 10:00 AM EDT
Days after US regulators gave the AstraZeneca - Oxford vaccine the green light to re-start its US-based trials, the FT is reporting new data that seems promising, even if it's still pretty preliminary.
In this article: AZN
Read
Biotech Stock Playbook In A Choppy Momentum Market
Article By: Rod Raynovich
Tuesday, September 29, 2020 4:57 AM EDT
Biotech stocks peaked in mid-July but we have assumed a fourth quarter rally driven by clinical news in oncology and important scientific breakthroughs in diagnostic testing for coronavirus and COVID vaccine data.
In this article: ABT, AZN, BMY, GSK, JNJ, MRK, RHHBY, GNMK, NVAX, OSUR, QDEL, HOLX, PACB, ABBV, AXDX, EDIT, CRSP
Read
Bulls And Bears Of The Week: Chevron, Oracle, Twitter And More
Article By: Benzinga
Saturday, September 26, 2020 5:55 PM EDT
Here are a few of this past week's most bullish and bearish posts that are worth another look.
In this article: AXP, AZN, CVX, AAPL, ORCL, MRNA, TWTR, DKNG
Read
AstraZeneca Has Lost The Lead In Race For Coronavirus Vaccine, Says SVB Leerink
Article By: Benzinga
Monday, September 21, 2020 12:04 PM EDT
AstraZeneca plc's prospects at being the first mover in the competition to develop a coronavirus vaccine have dimmed, according to an analyst at SVB Leerink.
In this article: AZN
Read
What's Moving The Markets On Monday?
Article By: Fiona Cincotta
Monday, September 14, 2020 4:14 AM EDT
The FTSE, along with its European peer are heading for a higher start boosted by vaccine optimism and ahead of a key day in Parliament for the Internal Markets Bill.
In this article: AZN, SFTBY, ARMH, NVDA, FXB
Read

PARTNER HEADLINES

Latest Tweets for $AZN

No tweets yet!

$AZN

When Profits and Politics Drive Science: Rushing a Vaccine to Market for a Vanishing Virus
Adam Reynolds 6/4/2020 5:09:08 PM

Yes and Fauci and other experts said corona is likely here to stay. We will probably have seasonal outbreaks every year. There will be plenty of time to profit from a vaccine. Bullish on $AZN, $MRNA.

1 to 1 of 1 comments